Matches in SemOpenAlex for { <https://semopenalex.org/work/W2518120872> ?p ?o ?g. }
- W2518120872 endingPage "1741" @default.
- W2518120872 startingPage "1736" @default.
- W2518120872 abstract "Animals are not commonly used to assess drug-drug interactions due to poor clinical translatability arising from species differences that may exist in drug-metabolizing enzymes and transporters, and their regulation pathways. In this study, a transgenic mouse model expressing human pregnane X receptor (PXR), constitutive androstane receptor (CAR), CYP3A4/CYP3A7, and CYP2D6 (Tg-composite) was used to investigate the effect of induction mediated by rifampin on the pharmacokinetics of tamoxifen and its metabolites. In humans, tamoxifen is metabolized primarily by CYP3A4 and CYP2D6, and multiple-day treatment with rifampin decreased tamoxifen exposure by 6.2-fold. Interestingly, exposure of tamoxifen metabolites 4-hydroxytamoxifen (4OHT), N-desmethyltamoxifen (NDM), and endoxifen also decreased. In the Tg-composite model, pretreatment with rifampin decreased tamoxifen area under the time-concentration curve between 0 and 8 hours (AUC0-8) from 0.82 to 0.20 µM*h, whereas AUC0-8 of 4OHT, NDM, and endoxifen decreased by 3.4-, 4.7-, and 1.3-fold, respectively, mirroring the clinic observations. In the humanized PXR-CAR (hPXR-CAR) model, rifampin decreased AUC0-8 of tamoxifen and its metabolites by approximately 2-fold. In contrast, no significant modulation by rifampin was observed in the nonhumanized C57BL/6 (wild-type) animals. In vitro kinetics determined in microsomes prepared from livers of the Tg-composite animals showed that, although Km values were not different between vehicle- and rifampin-treated groups, rifampin increased the Vmax for the CYP3A4-mediated pathways. These data demonstrate that, although the hPXR-CAR model is responsive to rifampin, the extent of the clinical rifampin-tamoxifen interaction is better represented by the Tg-composite model. Consequently, the Tg-composite model may be a suitable tool to examine the extent of rifampin-mediated induction for other compounds whose metabolism is mediated by CYP3A4 and/or CYP2D6." @default.
- W2518120872 created "2016-09-16" @default.
- W2518120872 creator A5008934311 @default.
- W2518120872 creator A5019127974 @default.
- W2518120872 creator A5021212416 @default.
- W2518120872 creator A5025738154 @default.
- W2518120872 creator A5037051254 @default.
- W2518120872 date "2016-08-18" @default.
- W2518120872 modified "2023-09-26" @default.
- W2518120872 title "Rifampin-Mediated Induction of Tamoxifen Metabolism in a Humanized PXR-CAR-CYP3A4/3A7-CYP2D6 Mouse Model" @default.
- W2518120872 cites W1554845361 @default.
- W2518120872 cites W1878723460 @default.
- W2518120872 cites W1964945591 @default.
- W2518120872 cites W1981563176 @default.
- W2518120872 cites W1985046754 @default.
- W2518120872 cites W1990285606 @default.
- W2518120872 cites W1997271604 @default.
- W2518120872 cites W2011257206 @default.
- W2518120872 cites W2017570888 @default.
- W2518120872 cites W2027376002 @default.
- W2518120872 cites W2027517951 @default.
- W2518120872 cites W2042538807 @default.
- W2518120872 cites W2066636198 @default.
- W2518120872 cites W2069002111 @default.
- W2518120872 cites W2071185486 @default.
- W2518120872 cites W2074335085 @default.
- W2518120872 cites W2084462922 @default.
- W2518120872 cites W2098388418 @default.
- W2518120872 cites W2100073637 @default.
- W2518120872 cites W2110057699 @default.
- W2518120872 cites W2111329465 @default.
- W2518120872 cites W2112533311 @default.
- W2518120872 cites W2118070545 @default.
- W2518120872 cites W2124120302 @default.
- W2518120872 cites W2125837299 @default.
- W2518120872 cites W2131138924 @default.
- W2518120872 cites W2136918221 @default.
- W2518120872 cites W2151389575 @default.
- W2518120872 cites W2152964734 @default.
- W2518120872 cites W2156455256 @default.
- W2518120872 cites W2166367122 @default.
- W2518120872 cites W2319543942 @default.
- W2518120872 cites W3131315330 @default.
- W2518120872 doi "https://doi.org/10.1124/dmd.116.072132" @default.
- W2518120872 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27538915" @default.
- W2518120872 hasPublicationYear "2016" @default.
- W2518120872 type Work @default.
- W2518120872 sameAs 2518120872 @default.
- W2518120872 citedByCount "7" @default.
- W2518120872 countsByYear W25181208722016 @default.
- W2518120872 countsByYear W25181208722017 @default.
- W2518120872 countsByYear W25181208722018 @default.
- W2518120872 countsByYear W25181208722020 @default.
- W2518120872 countsByYear W25181208722021 @default.
- W2518120872 countsByYear W25181208722022 @default.
- W2518120872 crossrefType "journal-article" @default.
- W2518120872 hasAuthorship W2518120872A5008934311 @default.
- W2518120872 hasAuthorship W2518120872A5019127974 @default.
- W2518120872 hasAuthorship W2518120872A5021212416 @default.
- W2518120872 hasAuthorship W2518120872A5025738154 @default.
- W2518120872 hasAuthorship W2518120872A5037051254 @default.
- W2518120872 hasBestOaLocation W25181208721 @default.
- W2518120872 hasConcept C104317684 @default.
- W2518120872 hasConcept C109650736 @default.
- W2518120872 hasConcept C112705442 @default.
- W2518120872 hasConcept C121608353 @default.
- W2518120872 hasConcept C126322002 @default.
- W2518120872 hasConcept C132040763 @default.
- W2518120872 hasConcept C185592680 @default.
- W2518120872 hasConcept C193264327 @default.
- W2518120872 hasConcept C2777176818 @default.
- W2518120872 hasConcept C2780035454 @default.
- W2518120872 hasConcept C33664856 @default.
- W2518120872 hasConcept C526171541 @default.
- W2518120872 hasConcept C530470458 @default.
- W2518120872 hasConcept C55493867 @default.
- W2518120872 hasConcept C62231903 @default.
- W2518120872 hasConcept C63932345 @default.
- W2518120872 hasConcept C71924100 @default.
- W2518120872 hasConcept C86339819 @default.
- W2518120872 hasConcept C86803240 @default.
- W2518120872 hasConcept C89311334 @default.
- W2518120872 hasConcept C98274493 @default.
- W2518120872 hasConceptScore W2518120872C104317684 @default.
- W2518120872 hasConceptScore W2518120872C109650736 @default.
- W2518120872 hasConceptScore W2518120872C112705442 @default.
- W2518120872 hasConceptScore W2518120872C121608353 @default.
- W2518120872 hasConceptScore W2518120872C126322002 @default.
- W2518120872 hasConceptScore W2518120872C132040763 @default.
- W2518120872 hasConceptScore W2518120872C185592680 @default.
- W2518120872 hasConceptScore W2518120872C193264327 @default.
- W2518120872 hasConceptScore W2518120872C2777176818 @default.
- W2518120872 hasConceptScore W2518120872C2780035454 @default.
- W2518120872 hasConceptScore W2518120872C33664856 @default.
- W2518120872 hasConceptScore W2518120872C526171541 @default.
- W2518120872 hasConceptScore W2518120872C530470458 @default.
- W2518120872 hasConceptScore W2518120872C55493867 @default.
- W2518120872 hasConceptScore W2518120872C62231903 @default.